The Alabama Innovation Corporation awarded two University of Alabama at Birmingham startups with grants during the second round of Innovate Alabama Supplemental Grant awards.
The Innovate Alabama Supplemental Grant Program awards funds to Alabama-based companies that have been granted Phase I or Phase II awards through the Federal Small Business Innovation Research Program or Federal Small Business Technology Transfer Program.
Eligible companies can apply to receive a match of up to 50 percent of their SBIR/STTR grants. Phase I Award recipients may receive up to $100,000, while Phase II Award recipients may receive up to $250,000.
The program awarded more than $3 million in grants during this round of funding to 19 winners, five of which were in the Birmingham area.
Of those five local winners, the two UAB startups are:
- Adjuvax, LLC, which specializes in vaccine adjuvant discovery and development. The $100,000 Adjuvax received from Innovate Alabama will be used to develop a new adjuvant formulation for various vaccines against infectious diseases.
- Tricorder Array Technologies received $250,000 to aid in developing the PenPal, a wireless device that collects environmental and mouse squeaks in research cages, to understand the behavior and environment influence on animal studies.
Adjuvax and Tricorder Array Technologies join seven UAB startups that received grants from the Alabama Innovation Corporation in 2022. Those startups include AeroNeph Therapeutics, AI Metrics, Endomimetics, Reliant Glycosciences, SunFire Biotechnologies, Trialtus Bioscience and TruSpin Nanomaterial Innovation.
(Courtesy of UAB)
